Lakewood-Amedex Biotherapeutics, Inc. (LABT) vs Silo Pharma, Inc. (SILO)
A side-by-side comparison of Lakewood-Amedex Biotherapeutics, Inc. and Silo Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LABT
Lakewood-Amedex Biotherapeutics, Inc.
$0.85HealthcareDelayed quote: Oct 6, 2026, 2:01 PM EDT
SILO
Silo Pharma, Inc.
$1.42HealthcareDelayed quote: Oct 6, 2026, 2:01 PM EDT
Total return — LABT vs SILO
growth of $100 · dividends reinvested · last 1yLABT -99.0% (-99.0%/yr)SILO -82.6% (-82.6%/yr)SILO compounded faster over this window
Log scale — wide-divergence pair
LABT SILO
LABT vs SILO: by the numbers
- •SILO is the larger company ($2M vs $1M market cap).
- •Both run net losses; LABT's is the smaller (0.00% vs -8269.53% net margin).
Metrics side by side
Valuation
| Metric | LABT | SILO |
|---|---|---|
| P/S ratio | N/A | 29.64 |
| P/B ratio | 0.34 | 0.33 |
Profitability
| Metric | LABT | SILO |
|---|---|---|
| Gross margin | 0.00% | -1128.89% |
| Operating margin | 0.00% | -5936.95% |
| Net margin | 0.00% | -8269.53% |
| ROE | -169.64% | -91.52% |
| ROIC | -163.98% | -91.31% |
Growth (annualized)
| Metric | LABT | SILO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 0.29% |
| Total return CAGR (5Y) | N/A | -61.41% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.